Plasma and Cyro: What’s in the Bag? (Video)
Dr. Yazer talks about plasma and cryo and what is really in the bag (30 minutes).
Challenging the Processes of Cell Salvage (Video)
Christine Windisch discusses the process of cell salvage while challanging some of the core principles (17 minutes).
Economics of Blood Management (Video)
Janet farwell discusses the econimoics of blood management with the Hemobag (22 minutes).
Bleeding and Clot Vulnerability (Video)
Dr. Wegner discusses the dynamics of bleeding and clot vulnerability (23 minutes).
Autotransfusion in Autologous Blood Management (Video)
John Rivera discusses the role of autotransfusion in a successuful blood management program (24 minutes).
Does the RBC Storage Lesion Matter Clinically? (Video)
Dr. Yazer discusses the deleterious clinical effects of RBC storage (36 minutes).
Principles of Hemostasis in the Coumadin Clinic (Video)
Dr. Ferris discusses the principles of hemostasis in the coumadin clinic (21 minutes).
Monitoring Hemostasis with the TEG® (Video)
Mike Miller from Haemonetics Corporation discusses hemostasis monitoring with the TEG (22 minutes).
Evaluation of the Quadrox-I Neonatal Oxygenator with an Integrated Arterial Filter
This study investigated the new QUADROX-i Neonatal Oxygenator (D-72145, Maquet, Hirrlingen, Germany) with an integrated arterial filter in terms of the hemodynamic properties and ability to clear GME in response to hypothermic versus normothermic conditions, open versus closed arterial filter purge line, and varying flow rates in a simulated CPB circuit identical to that of the clinical setting.
Storage Time of Allogeneic Red Blood Cells is Associated With Risk of Severe Postoperative Infection After Coronary Artery Bypass Grafting
We therefore examined the association between the age of transfused RBCs and development of severe postoperative infection following coronary artery bypass grafting (CABG) in a large population-based cohort study.
Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 on Coagulation and Inflammatory Response When Used as Priming Solutions for Cardiopulmonary Bypass
This prospective, randomized and controlled trial compares the use of human albumin (HA) and hydroxyethyl starch (HES) 130/0.4 in the priming solution for a non-biocompatible cardiopulmonary bypass (CPB) circuit.
Heparinized Cardiopulmonary Bypass Circuits and Low Systemic Anticoagulation: An Analysis of Nearly 6000 Patients Undergoing Coronary Artery Bypass Grafting
Heparin coating of cardiopulmonary bypass circuits reduces the inflammatory response and increases the thromboresistance during extracorporeal circulation. These properties enables a lower systemic heparin dose, which has been shown to reduce the need for blood transfusions. Experience with this technique accumulated over 11 years has been analyzed.